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Abstract
A newborn girl presented with massive proptosis of the right eye. Physical and radiologic
examination disclosed that the primary orbital mass was confined to the site. A diagnosis of malignant
rhabdoid tumor was made by histopathologic examination of an incisional biopsy specimen.
Exenteration was performed, and the resection margins were free from tumor cells. However, distant
metastasis developed in the liver 1 month after surgery. Despite chemotherapy, the patient died 2
months later due to tumor invasion into the central nervous system, which was confirmed by autopsy.
To the best of our knowledge, this is the first case of congenital orbital malignant rhabdoid tumor
showing systemic metastasis after exenteration, which suggests the need for aggressive systemic
treatment rather than exenteration, even in a case of locally confined tumor.
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Malignant rhabdoid tumor (MRT) is a rare but highly malignant neoplasm. Since Rootman et
al. [1] originally reported primary MRT of the orbit in 1989, there have been several published
cases of MRT of the orbit [2-5]. Although MRT characteristically has an early age at onset,
MRT occasionally presenting at birth is referred to as congenital. There have been only two
published reports of cases with congenital MRT confined to the orbit [6,7]. Interestingly, both
of these patients had a good outcome, showing complete remission after chemotherapy
followed by surgical resection and chemotherapy with Gamma Knife radiosurgery,
respectively. Therefore, the role of exenteration has not been established for congenital orbital
MRT. Here, we describe a case of congenital orbital MRT which was initially treated by
exenteration; the patient later developed systemic metastasis and finally succumbed to the
tumor despite chemotherapy.
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Case Report
A newborn girl presented with massive proptosis of the right eye, which was identified as
secondary to an orbital mass found at 35 weeks of gestation by prenatal ultrasonography (fig.
1 a). She was born full term to a healthy mother after a normal pregnancy and weighed 2,590
g at birth. A large, firm mass completely filled the right orbit and was associated with
hemorrhage (fig. 1 b). The right pupil was fixed and not reactive to light. Magnetic resonance
imaging of the head and orbits revealed a large, well-delineated right orbital mass with no
evidence of surrounding bony erosion or intracranial extension (fig. 1 c–e). The remainder of
the physical examination was unremarkable, and the systemic evaluation, including chest X-
ray and computed tomography of the chest and abdomen, showed no evidence of a primary
nonocular tumor or metastatic disease.
Incisional biopsy of the orbital mass was performed on day 13 of life. Histopathologically, the
tumor consisted of an infiltrating small-cell neoplasm that was partially necrotic. Most cells
were round with prominent, vesicular nuclei and distinct nucleoli. There were abundant
amphophilic or faintly eosinophilic cytoplasmic inclusions (fig. 2a). Immunohistochemical
staining was positive for vimentin, cytokeratin, epithelial membrane antigen, and MIC-2
(CD99), but negative for desmin, smooth muscle actin, HMB-45, CD31, CD34, S-100 protein,
neuron-specific enolase, and chromogranin A (fig. 2b). All of these findings were consistent
with a diagnosis of MRT.
On day 26 of life, exenteration of the right orbit was performed, and the resection margins were
free from tumor cells. She remained in clinical remission for 1 month after surgery.
Unfortunately, after this period, multiple hypoechoic nodules, which signified tumor
metastasis, were noticed on follow-up abdominal ultrasonography. On that day, chemotherapy
was initiated as follows: vincristine (0.025 mg/kg) on days 1 and 2, actinomycin D (0.075 mg/
kg) on days 1–5, and cyclophosphamide (30 mg/kg) on day 1. However, at 1 week after the
completion of the first cycle of chemotherapy, a computed tomography scan showed multiple,
round, hypodense nodules in the lung and liver, which suggested progression of distant tumor
metastasis. We recommended a second cycle of chemotherapy with the addition of ifosfamide
and etoposide, but her parents refused any further active treatment. Following conservative
treatment, the patient died 2 months later. At autopsy, extensive metastatic tumors were
observed in the upper portion of the pons, right retro-orbital area, both lungs, chest wall, liver,
and retroperitoneum. The masses were firm, irregular shaped, and fixed to adjacent organs (fig.
3).
Discussion
MRT was initially thought to be a variant of Wilms tumor [8], but it is now known that rhabdoid
tumors of the central nervous system (atypical teratoid/rhabdoid tumor), soft tissue (extrarenal
MRT), and kidney (rhabdoid tumor of the kidney) have a genetic origin distinct from
nephroblastoma [9].
The histopathologic diagnosis of extrarenal rhabdoid tumor is based on the presence of
characteristic features similar to those found in kidney MRT. These include large oval to
polygonal cells with abundant eosinophilic cytoplasm, large vesicular nuclei with prominent
nucleoli, and conspicuous cytoplasmic inclusions. Ultrastructurally, cytoplasmic inclusions
are composed of concentric arrays of parallel intermediate filaments, 6–9 nm in diameter. The
filamentous cytoplasmic inclusions are not membrane bound and occasionally incorporate lipid
droplets or mitochondria [10]. The differential diagnosis includes round-cell tumors such as
rhabdomyosarcoma, neuroblastoma, lymphoma, Ewing sarcoma/primitive neuroectodermal
tumor, and malignant melanoma. Immunohistochemistry is helpful in establishing the
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diagnosis of rhabdoid tumor, which characteristically shows a pattern of positive
immunoreactivity for vimentin, cytokeratin, and epithelial membrane antigen. Vimentin is
usually positive in rhabdoid tumor, but immunoreactivity for cytokeratin and epithelial
membrane antigen is more variable. Negative staining for muscle markers, histiocytic markers,
HMB-45, and S100 protein serves to exclude myogenic and histiocytic neoplasms, as well as
malignant melanoma [11].
The treatment modality for orbital MRT is not yet established, and the role of exenteration is
not clear. Interestingly, two previous reports of congenital MRT confined to the orbit showed
good prognosis after combined treatment: chemotherapy followed by surgical resection of
residual tumor, or Gamma Knife radiosurgery after tumor burden reduction with chemotherapy
[6,7]. Briefly, the former case was treated with three cycles of the ICE (ifosfamide, carboplatin,
and etoposide) regimen following monthly intrathecal injections of methotrexate and
cytarabine and high-dose chemotherapy in advance of surgical resection of the tumor, and
completed by three additional cycles of chemotherapy with the same regimen [6]. The latter
case was first treated with a cycle of cisplatin, etoposide, and vincristine. However, because
of tumor progression, two cycles of ifosfamide and doxorubicin were included to reduce the
tumor burden. After performing Gamma Knife radiosurgery, treatment was completed with
three additional cycles of chemotherapy with the same regimen, followed by high-dose
chemotherapy with melphalan and cyclophosphamide, and ifosfamide and thiotepa [7].
Exenteration was performed in our patient as a result of the finding that the tumor appeared to
be confined to the orbit, with no sign of systemic metastasis. Unfortunately, distant metastasis
was found in the liver 1 month after surgery. Although the chemotherapy regimen that we used
was not exactly the same as those in the previous cases, despite the chemotherapy, multiple
systemic metastases progressed to the lung and liver. The patient died 4 months after initial
diagnosis from distant metastasis in the pons and lung, which was confirmed by autopsy.
Although extremely rare, congenital MRT of the orbit should be considered in the setting of
rapidly expanding orbital lesions appearing in the neonatal period, and we believe this case
suggests the restricted role of exenteration for congenital orbital MRT.
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Fig. 1.
a Ultrasonography at 35 weeks' gestation, showing orbital mass (arrowhead) and displaced
eyeball (arrow). b Clinical photograph taken on day 1 of life, showing a huge mass in the right
orbit and proptosis. Axial T1 (c), axial T2 (d), and sagittal T1 (e) magnetic resonance imaging
of the orbit after gadolinium injection; well-enhanced and marginated heterogeneous tumor
without intracranial extension is seen.
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Fig. 2.
a Light microscopy image of the orbital tumor, showing sheets of polygonal and spindle cells
with vesicular nuclei, prominent nucleoli, and eosinophilic cytoplasmic inclusions. H.E.
Original magnification, ×400. b Immunohistochemical analysis showing tumor cells positive
for MIC-2 (CD99). Original magnification, ×400.
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Fig. 3.
Autopsy findings of tumor recurrence at exenterated site (top left), pons (top right), posterior
aspect of the lung (bottom left), liver (bottom center), and retroperitoneum (bottom right).
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